Search results
Results from the WOW.Com Content Network
Flibanserin [1] and Bremelanotide [3] were developed for raising sexual desire in women, whereas similar conditions in men are treated using medications for sexual dysfunction. [4] On the other hand, down-regulation on libido comes in two approaches: a direct or an indirect mechanism.
Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). [ 4 ] [ 5 ] The medication improves sexual desire, increases the number of satisfying sexual events, and decreases the distress associated with low sexual desire. [ 6 ]
Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women. [2] Specifically it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship.
Stroke guidelines now include risks that are unique to women. The American Stroke Association, a division of the American Heart Association, released new stroke prevention guidelines this week for ...
They occur most frequently in women between 50 and 69 years of age but can occur in women of any age, including young girls. They are not typically aggressive and are usually unilateral; [26] they are therefore usually treated with surgery alone. Sex cord-stromal tumors are the main hormone-producing ovarian tumors. [32]
More women may benefit from gene testing for hereditary breast or ovarian cancer, especially if they've already survived cancer once, an influential health group recommended Tuesday.
Ovarian drilling is a surgical alternative to CC treatment or recommended for women with WHO Group II ovulation disorders. [6] Other non-surgical medical options in the treatment of PCOS include the oestrogen receptor modulator tamoxifen , aromatase inhibitors , insulin sensitising drugs, and hormonal ovarian stimulation. [ 9 ]
Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies).